A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)

Thumbnail Image

Tarih

2016

Yazarlar

Süreli Yayın başlığı

Süreli Yayın ISSN

Cilt Başlığı

ISSN

Cilt

Sayı

Yayınevi

ELSEVIER SCI LTD

Özet

Açıklama

Anahtar kelimeler

Anastrozole, Gefitinib, Metastatic breast cancer, Endocrine resistance

Alıntı

URI

https://openaccess.acibadem.edu.tr/handle/11443/8842

Koleksiyonlar

WOS

Endorsement

Review

Supplemented By

Referenced By